Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Different Doses of Pegylated Interferon α-2b Injection Nebulization Therapy for Common Hand, Foot, and Mouth Disease (HFMD).

NCT07008755 is registered in ClinicalTrials.gov with Zhengzhou Children's Hospital, China as lead sponsor.

NCT NCT07008755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Different Doses of Pegylated Interferon α-2b Injection Nebulization Therapy for Common Hand, Foot, and Mouth Disease (HFMD).
Lead sponsor
Zhengzhou Children's Hospital, China
Phase
Not applicable
Overall status
Recruiting
Start date
July 31, 2024
Completion date
December 31, 2027
Enrollment
90 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hfmd